|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-1-18
|
|
pubmed:abstractText |
To assess patients who had radical prostatectomy (RP) and pelvic lymph node dissection (PLND) for pT2-4 N0M0 prostate cancer, to determine if LN yield affects the risk of biochemical failure (BCF), as the extent of PLND at the time of RP has become increasingly uncertain with the decreasing trend in tumour stage.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
176-9
|
|
pubmed:dateRevised |
2010-6-7
|
|
pubmed:meshHeading |
pubmed-meshheading:19549117-Adult,
pubmed-meshheading:19549117-Aged,
pubmed-meshheading:19549117-Humans,
pubmed-meshheading:19549117-Lymph Node Excision,
pubmed-meshheading:19549117-Lymph Nodes,
pubmed-meshheading:19549117-Male,
pubmed-meshheading:19549117-Middle Aged,
pubmed-meshheading:19549117-Neoplasm Recurrence, Local,
pubmed-meshheading:19549117-Prognosis,
pubmed-meshheading:19549117-Prostate,
pubmed-meshheading:19549117-Prostate-Specific Antigen,
pubmed-meshheading:19549117-Prostatectomy,
pubmed-meshheading:19549117-Prostatic Neoplasms,
pubmed-meshheading:19549117-Risk Factors,
pubmed-meshheading:19549117-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy.
|
|
pubmed:affiliation |
Department of Urology, Columbia University Medical Center, New York, NY 10032, USA. amm251@columbia.edu
|
|
pubmed:publicationType |
Journal Article
|
